Board

Dr Sandy Primrose
Chairman
Dr. Sandy Primrose is a non-executive director (NXD) and Chairman of the Board of Directors of Fios Genomics. He is currently NXD Chairman at Arrayjet Ltd and...
...Cellexus Limited and he represents The London Technology Fund and Esperante Ventures. He is also on the Board of Immune Targeting Systems Ltd. Sandy is the senior partner at Business and Technology Management, a biotechnology and healthcare consultancy practice. Previously, Sandy was an academic at Warwick University and then held posts as Senior Director of Drug Development at Searle Research and Development and then managed the Life Science business of Amersham International (now part of GE). After that he held senior management positions in a number of early stage companies as well as serving on the board of the Microbiological Research Authority (a Special Health Authority) and then the Health Protection Agency.
read more...
Nadia Whittley
CHIEF EXECUTIVE OFFICER
Nadia is a seasoned Senior Executive in the Life Science sector spanning several therapeutic areas and across different geographies (EMEA, Asia Pacific and North ...
... America). She has held senior positions at Alium Medical Limited, Allergan, Boston Scientific and Medtronic. Most recently Nadia has served as the Partner & Managing Director Europe for Tefen Management Consulting. Nadia has a strong background in business management and product commercialisation.
read more...
Dr Nick Miller-Jones
Founder and Non-Executive Director
Nick led the Life Sciences Division of Scientific Generics Ltd, one of the UK’s leading technology consultancy companies and has over 20 years experience...
... in the biotech, life sciences and healthcare industries. He has worked in a number of disciplines including lab-based point-of-care assay development, market analysis and positioning, market entry strategy, identification of companies for acquisition and due diligence on life science companies on behalf of investors.
read more...
Tristan Sillars
Finance and Operations Director
A Chartered Accountant, Tristan has concentrated on interim and part-time Head of Finance roles for the last five years as well as raising money for SMEs, aided by his corporate ...
... finance and financial modelling expertise. Previously, Tristan worked for KPMG Transaction Services, covering a wide range of deal activity across the UK.
read more...
Sarah Couch
Chief Technical Officer
Sarah has a technical background in assay development and over 16 years of practical experience of research and development, quality and regulatory affairs...
... within the IVD industry at Dako and Thermo Fisher Scientific. She has extensive experience of the IVD product cycle from project initiation through to launch and beyond. Since 2011 she has worked as an independent consultant, providing a wide range of assistance to IVD start-ups, focusing mainly on regulatory compliance and quality management.
read more...
Dr Elisabeth Parker
Non-Executive Director
Elisabeth represents Cancer Research Technology Ltd (CRT), the development and commercialisation arm of Cancer Research UK. Elisabeth has almost 20 years’ ...
... experience of R&D and commercialisation of translational research through licensing and spin-out routes. She has worked in academia, industry and the charity sector and also serves as a non-executive Director of Azeria Therapeutics Ltd. Prior to joining CRT, Elisabeth was Head of Research at KS Biomedix, a UK quoted Biopharmaceutical company that developed diagnostic and therapeutic antibodies. Elisabeth holds a PhD from the Medical Faculty, Lund University, Sweden.
read more...
David Denny
Non-Executive Director
David represents Longwall Ventures. He started his career as a graduate engineer in Carnaud Metalbox (now Crown Cork), working in a range of roles from R&D to production...
... and project management. David spent much of his career living and working overseas in Spain, Argentina, Belgium and France. David did his MBA at Harvard Business School, after which he joined Z Corporation, an MIT licensee start up. He spent several years growing the European and Asian businesses before entering the venture industry. David predominantly focuses on physical science and engineering opportunities.
read more...
Dr Alex Buchan
Observer
Alex represents NorthStar Ventures. He joined Northstar in September 2004 following a series of senior commercial roles in the biotechnology sector: Cybersense, Compugen, ...
... SDI Europe, EnSys Europe and Archaeus. Alex completed a PhD in Microbiology before spending 3 years in London as a stockbroker for UBS Phillips and Drew
read more...